| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 11 5483-5491, Copyright © 1997 by American Association of Immunologists
ARTICLES |
RJ Steptoe, F Fu, W Li, ML Drakes, L Lu, AJ Demetris, S Qian, HJ McKenna and AW Thomson
Thomas E. Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh, PA 15213, USA.
Treatment of mice with the recently cloned hemopoietic growth factor Flt3 ligand (FL; 10 microg/day for 10 days) resulted in a large increase in myeloid lineage cells within the liver. While the number of nonparenchymal cells (NPC) harvested from liver increased about 9-fold, a 90-fold increase was observed in the proportion of CD11c+ dendritic cells (DC) recovered from NPC following overnight (18-h) culture in granulocyte-macrophage CSF. In contrast, only a 50% increase was seen in CD11c+ cells within heart single cell suspensions and in the number of DC obtained from hearts after 18-h culture. Liver NPC and heart cell suspensions freshly isolated from 10-day FL-treated animals exhibited increased T cell allostimulatory capacity compared with controls. Overnight cultured DC from livers of FL-treated animals expressed both higher levels of costimulatory molecules (CD80 and CD86) and allostimulatory activity than those from controls. Heart-derived DC also displayed enhanced stimulatory capacity. Pretreatment of organ donors with FL for either 5 or 10 days before transplant of organs to normal recipients abrogated the spontaneous liver allograft acceptance normally observed and resulted in delayed or acute graft rejection (median survival times, 40 and 12 days, respectively). Heart rejection was significantly accelerated by pretreatment of donors with FL for 5 or 10 days (median survival times, 8 and 7 days, respectively, vs 12 days in controls). These novel findings reveal the potent immunologic adjuvant properties of FL in vivo. They also show that substantial augmentation of the number of potential allostimulatory cells in donor organs before transplantation favors rejection rather than tolerance induction.
This article has been cited by other articles:
|
|
 |
|
  M.-F. Mashreghi, R. Klemz, I. S. Knosalla, B. Gerstmayer, U. Janssen, R. Buelow, A. Jozkowicz, J. Dulak, H.-D. Volk, and K. Kotsch Inhibition of Dendritic Cell Maturation and Function Is Independent of Heme Oxygenase 1 but Requires the Activation of STAT3 J. Immunol., June 15, 2008; 180(12): 7919 - 7930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tsung, N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury J. Leukoc. Biol., January 1, 2007; 81(1): 119 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, A. Castellaneta, A. De Creus, W. J. Shufesky, A. E. Morelli, and A. W. Thomson Heart, but Not Skin, Allografts from Donors Lacking Flt3 Ligand Exhibit Markedly Prolonged Survival Time J. Immunol., May 15, 2004; 172(10): 5924 - 5930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-F. Wu, T.-M. Liu, Y.-C. Lin, H.-K. Sytwu, H.-F. Juan, S.-T. Chen, K.-L. Shen, S.-C. Hsi, and S.-L. Hsieh Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication J. Leukoc. Biol., February 1, 2004; 75(2): 293 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Pillarisetty, A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo Liver Dendritic Cells Are Less Immunogenic Than Spleen Dendritic Cells because of Differences in Subtype Composition J. Immunol., January 15, 2004; 172(2): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice J. Immunol., January 1, 2004; 172(1): 240 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, and R. P. DeMatteo Murine Flt3 Ligand Expands Distinct Dendritic Cells with Both Tolerogenic and Immunogenic Properties J. Immunol., April 1, 2003; 170(7): 3554 - 3564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A H Lau and A W Thomson Dendritic cells and immune regulation in the liver Gut, February 1, 2003; 52(2): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Eto, H. Hackstein, K. Kaneko, K. Nomoto, and A. W. Thomson Promotion of Skin Graft Tolerance Across MHC Barriers by Mobilization of Dendritic Cells in Donor Hemopoietic Cell Infusions J. Immunol., September 1, 2002; 169(5): 2390 - 2396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Brissette-Storkus, S. M. Reynolds, A. J. Lepisto, and R. L. Hendricks Identification of a Novel Macrophage Population in the Normal Mouse Corneal Stroma Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2264 - 2271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuchiya, K. Chida, T. Suda, E. E. Schneeberger, and H. Nakamura Dendritic Cell Involvement in Pulmonary Granuloma Formation Elicited by Bacillus Calmette-Guerin in Rats Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1640 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Steptoe, J. M. Ritchie, and L. C. Harrison Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice J. Immunol., May 15, 2002; 168(10): 5032 - 5041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Teshima, P. Reddy, K. P. Lowler, M. A. KuKuruga, C. Liu, K. R. Cooke, and J. L. M. Ferrara Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8alpha + dendritic cells and reduces experimental acute graft-versus-host disease Blood, March 1, 2002; 99(5): 1825 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, and S. Qian IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance J. Immunol., May 1, 2001; 166(9): 5619 - 5628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. O'Connell, A. E. Morelli, A. J. Logar, and A. W. Thomson Phenotypic and Functional Characterization of Mouse Hepatic CD8{alpha}+ Lymphoid-Related Dendritic Cells J. Immunol., July 15, 2000; 165(2): 795 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Morelli, M. A. Antonysamy, T. Takayama, H. Hackstein, Z. Chen, S. Qian, N. B. Zurowski, and A. W. Thomson Microchimerism, Donor Dendritic Cells, and Alloimmune Reactivity in Recipients of Flt3 Ligand-Mobilized Hemopoietic Cells: Modulation by Tacrolimus J. Immunol., July 1, 2000; 165(1): 226 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wang, S. E. Braun, G. Sonpavde, and K. Cornetta Antileukemic Activity of Flt3 Ligand in Murine Leukemia Cancer Res., April 1, 2000; 60(7): 1895 - 1900. [Abstract] [Full Text]
|
|
|
|
|
|
A. Ribas, L. H. Butterfield, B. Hu, V. B. Dissette, W. S. Meng, A. Koh, K. J. Andrews, M. Lee, S. N. Amar, J. A. Glaspy, et al. Immune Deviation and Fas-mediated Deletion Limit Antitumor Activity after Multiple Dendritic Cell Vaccinations in Mice Cancer Res., April 1, 2000; 60(8): 2218 - 2224. [Abstract] [Full Text]
|
|
|
|
|
|
L. Gorczynski, Z. Chen, J. Hu, Y. Kai, J. Lei, V. Ramakrishna, and R. M. Gorczynski Evidence That an OX-2-Positive Cell Can Inhibit the Stimulation of Type 1 Cytokine Production by Bone Marrow-Derived B7-1 (and B7-2)-Positive Dendritic Cells J. Immunol., January 15, 1999; 162(2): 774 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Semple, E. R. Speck, D. Cosgrave, A. H. Lazarus, V. S. Blanchette, and J. Freedman Extreme Leukoreduction of Major Histocompatibility Complex Class II Positive B Cells Enhances Allogeneic Platelet Immunity Blood, January 15, 1999; 93(2): 713 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pulendran, J.L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C.R. Maliszewski Prevention of Peripheral Tolerance by a Dendritic Cell Growth Factor: Flt3 Ligand as an Adjuvant J. Exp. Med., December 7, 1998; 188(11): 2075 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Shaw, A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic3 Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy J. Immunol., September 15, 1998; 161(6): 2817 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Antonysamy, R. J. Steptoe, A. Khanna, W. A. Rudert, V. M. Subbotin, and A. W. Thomson Flt-3 Ligand Increases Microchimerism But Can Prevent the Therapeutic Effect of Donor Bone Marrow in Transiently Immunosuppressed Cardiac Allograft Recipients J. Immunol., April 15, 1998; 160(8): 4106 - 4113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Asavaroengchai, Y. Kotera, and J. J. Mule Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery PNAS, January 22, 2002; 99(2): 931 - 936. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
